% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • sertoli_cell sertoli_cell Oct 16, 2012 5:01 PM Flag

    25 by friday

    AEGR to be best-in-class, standard-of-care for HoFH. It will be cycled on and off w/ apheresis so the liver can rid itself of excess lipids. Heavy institutional ownership here. Look for this orphan drug player to be scooped up. Big pharma let ALXN get away w/ their orphan drug, now they're too expensive to be acquired. AEGR has potential (heterozygous and/or pediatric expansion) to generate excess of 1/2 billion/year.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.65-0.10(-3.64%)Sep 26 4:00 PMEDT